QT Vascular subsidiary TriReme Medical touted angiographic data today from a 24-month follow-up of patients treated with its Chocolate Heart drug-coated balloon.
The Chocolate Heart device is a paclitaxel-coated version of the company’s Chocolate coronary balloon that is commercially available in the U.S. The combo therapy was designed to reduce the incidence of repeat procedures and minimize the need for a stent, according to TriReme.
Get the full story at our sister site, Drug Delivery Business News.
The post TriReme Medical touts Chocolate drug-coated balloon data appeared first on MassDevice.
from MassDevice http://ift.tt/2sFjfD6
Cap comentari:
Publica un comentari a l'entrada